Microbiome Modulation as a Determinant of Cancer Therapy Response: Highlights from ESCMID 2026
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research highlights the role of the microbiome in cancer development, progression, and response to therapy. The microbiome is being explored as a potential determinant of response to various cancer treatments, including immunotherapy. Studies are investigating the complex relationships between the microbiome, cancer, and therapeutic outcomes, with findings suggesting a possible link between the gut microbiome and treatment response in certain types of cancer.
Full coverage
12345678